OncLive® On Air
/
FDA Approval Insights: Brexucabtagene Autoleucel in Relapsed/Refractory B-ALL
Our original embed player - you can use this to maintain continuity with any other episodes you've already embedded. Otherwise we'd suggest
upgrading to our new player.